Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
RESEARCH TOOLSreports
Holding PRLD?
Track your performance easily
Prelude Therapeutics (PRLD) Ownership Overview
60.88% Insiders
6.01% Mutual Funds
<0.01% Other Institutional Investors
4.09% ETFs
29.02% Public Companies and
Individual Investors
The ownership structure of Prelude Therapeutics (PRLD) stock is a mix of institutional, retail, and individual investors. Approximately 10.10% of the company’s stock is owned by Institutional Investors, 60.88% is owned by Insiders, and 29.02% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,646,056 | Insider | 25.24% | 13,733,412 | |
| 10,123,824 | Institution | 24.00% | 13,059,733 | |
| 9,252,951 | Insider | 21.94% | 11,936,307 | |
| 4,908,086 | Insider | 11.10% | 6,331,431 | |
| 4,133,000 | Institution | 9.80% | 5,331,570 | |
| 997,405 | Institution | 2.36% | 1,286,652 | |
| 927,934 | Institution | 2.20% | 1,197,035 | |
| 620,026 | Institution | 1.47% | 799,834 | |
| 518,343 | Institution | 1.23% | 668,662 | |
| 500,098 | Insider | 1.19% | 645,126 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 927,934 | Institution | 2.20% | 1,197,035 | |
| 620,026 | Institution | 1.47% | 799,834 | |
| 327,699 | Institution | 0.78% | 422,732 | |
| 181,201 | Institution | 0.43% | 233,749 | |
| 154,068 | Institution | 0.37% | 198,748 | |
| 114,000 | Institution | 0.27% | 147,060 | |
| 62,024 | Institution | 0.15% | 80,011 | |
| 40,990 | Institution | 0.10% | 52,877 | |
| 27,608 | Institution | 0.07% | 35,614 | |
| 20,318 | Institution | 0.05% | 26,210 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 720,427 | Institution | 1.71% | 1,491,284 | |
| 207,507 | Institution | 0.49% | 429,539 | |
| 357,890 | Institution | 0.85% | 429,468 | |
| 129,878 | Institution | 0.31% | 155,854 | |
| 60,420 | Institution | 0.14% | 125,069 | |
| 82,945 | Institution | 0.20% | 102,852 | |
| 64,409 | Institution | 0.15% | 79,867 | |
| 15,986 | Institution | 0.04% | 38,207 | |
| 30,575 | Institution | 0.07% | 36,690 | |
| 9,051 | Institution | 0.02% | 18,736 |
FAQ
Who Owns Prelude Therapeutics (PRLD)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 60.88% is held by insiders, and 29.02% is held by retail investors.
What percentage of Prelude Therapeutics (PRLD) stock is held by institutional investors?
According to the latest TipRanks data, approximately <0.01% of Prelude Therapeutics (PRLD) stock is held by institutional investors.
What percentage of Prelude Therapeutics (PRLD) stock is held by retail investors?
According to the latest TipRanks data, approximately 29.02% of Prelude Therapeutics (PRLD) stock is held by retail investors.
Who owns the most shares of Prelude Therapeutics (PRLD)?
David Bonita owns the most shares of Prelude Therapeutics (PRLD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.